REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam

Clinical trial NCT02880163 · RECRUITING

Trial details

NCT number: NCT02880163
Sponsor: Arsenal Medical, Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hemorrhagic Shock Trauma Exsanguinating Hemorrhage Shock; Traumatic

Start date: 2025-08-07
Primary completion: 2026-10-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.